Where To Report Waste

Fraud, Abuse, Or Retaliation

NIH Should Improve Its Management of Contracts for the Acquisition of Information Technology

Submitting OIG:

Department of Health & Human Services OIG

Date Issued:

Monday, June 5, 2023

Agency Reviewed / Investigated:

Department of Health & Human Services

Submitting OIG-Specific Report Number:

A-18-21-11500

Component, if applicable:

National Institutes of Health

National Institutes of Health

Location(s):

DC,

United States

Type of Report:

Audit

Questioned Costs:

$0

Funds for Better Use:

$0

Number of Recommendations:

3

Report updated under NDAA 5274:

No

View Document:

Attachment	Size
182111500.pdf	1.97 MB

Related Open Recommendations

Recommendation Number	Recommendation Status	Significant Recommendation	Additional Details
23-A-18-084.01	Open	No
We recommend that the National Institutes of Health provide additional training and implement oversight controls to ensure that acquisition workforce and program staff adhere to the roles and responsibilities defined in the HHS Policy for Information Technology Procurements - Security And Privacy Language, including that staff must incorporate all applicable information security and privacy requirements, contract language, and clauses into acquisition documents; and complete the Information Security Program Requirements Checklist and Certification properly for all acquisitions involving the procurement of information and IT products and services.
23-A-18-084.02	Open	No
We recommend that the National Institutes of Health provide additional training and implement oversight controls to ensure that contractor performance assessments are completed and uploaded to the Contractor Performance Assessment Reporting System timely.
23-A-18-084.03	Open	No
We recommend that the National Institutes of Health provide additional training and implement oversight controls to ensure that NIH Competition Advocates prepare and submit timely Annual Competition Advocate Reports to HHS in accordance with the requirements of FAR 6.502(b)(2) and the HHS Competition Advocacy Directive.